1. Home
  2. OCS vs KRP Comparison

OCS vs KRP Comparison

Compare OCS & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • KRP
  • Stock Information
  • Founded
  • OCS 2003
  • KRP 2013
  • Country
  • OCS Switzerland
  • KRP United States
  • Employees
  • OCS N/A
  • KRP N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • KRP Oil & Gas Production
  • Sector
  • OCS Health Care
  • KRP Energy
  • Exchange
  • OCS Nasdaq
  • KRP Nasdaq
  • Market Cap
  • OCS 956.4M
  • KRP 1.1B
  • IPO Year
  • OCS N/A
  • KRP 2017
  • Fundamental
  • Price
  • OCS $17.09
  • KRP $13.70
  • Analyst Decision
  • OCS Strong Buy
  • KRP Hold
  • Analyst Count
  • OCS 4
  • KRP 5
  • Target Price
  • OCS $35.75
  • KRP $17.20
  • AVG Volume (30 Days)
  • OCS 13.4K
  • KRP 419.7K
  • Earning Date
  • OCS 11-06-2025
  • KRP 11-06-2025
  • Dividend Yield
  • OCS N/A
  • KRP 12.56%
  • EPS Growth
  • OCS N/A
  • KRP N/A
  • EPS
  • OCS N/A
  • KRP N/A
  • Revenue
  • OCS $960,668.00
  • KRP $312,566,668.00
  • Revenue This Year
  • OCS $11.49
  • KRP $11.24
  • Revenue Next Year
  • OCS $1,784.02
  • KRP $2.96
  • P/E Ratio
  • OCS N/A
  • KRP N/A
  • Revenue Growth
  • OCS N/A
  • KRP N/A
  • 52 Week Low
  • OCS $11.78
  • KRP $10.98
  • 52 Week High
  • OCS $23.08
  • KRP $16.99
  • Technical
  • Relative Strength Index (RSI)
  • OCS 44.25
  • KRP 44.77
  • Support Level
  • OCS $16.00
  • KRP $13.34
  • Resistance Level
  • OCS $17.35
  • KRP $13.80
  • Average True Range (ATR)
  • OCS 0.39
  • KRP 0.24
  • MACD
  • OCS 0.06
  • KRP 0.00
  • Stochastic Oscillator
  • OCS 51.67
  • KRP 49.56

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About KRP Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.

Share on Social Networks: